AHRO-Canada to oversee commercialization and IP activities

As part of its effort to broaden its horizon to fit its vision of becoming one of the leading research institutes in the world, the AHRO Network has established its Canada Office with the aim of hosting its commercialization and intellectual property activities. With aim of developing small drug molecules, the organization would pursue the “from bench to clinic” agenda where promising drug candidates will either be patented to a pharmaceutical or biotechnological company. The office which is to be based in Toronto, Canada would be officially launched in December during the Global Forum on Long COVID-19. Furthermore, AHRO-Canada would be involved in registration of any drug or medical device innovated by AHRO Network.